Fluticasone Furoate Slows Loss of Lung Function in COPD
Alone or in combination, reduces rate of FEV1 decline in those with moderate COPD and high risk of CVD
mAb Glucagon Receptor Blocker Suitable for Further Development
REGN1193 inhibited glucose increase stimulated by glucagon in dose-dependent manner
More Than Two-Thirds of Post-Op Patients Have Unused Opioids
Further, patients report low rates of proper disposal of unused opioids
Moms’ Prior Flu Vaccine Doesn’t Weaken Newborns’ Benefit
Initial antibody response may weaken with more vaccines, but benefits at delivery not affected
Loss of Smell May Affect Nutrition in Patients With Renal Disease
Proof-of-concept study shows increase in odor identification score with intranasal theophylline
Lisdexamfetamine Dimesylate Has Early Benefit in Binge Eating
Improvements in efficacy measures as early as week one favoring lisdexamfetamine dimesylate
FDA Approves Mavyret for Hepatitis C
Combo drug is first approved therapy for hepatitis C to require as few as eight weeks of treatment
Stopping Statins After Initial Stroke Raises Risk of Recurrence
Findings based on patients discontinuing therapy three to six months after stroke
Genetic Variation Impacts Pharmacokinetics of Exemestane
Significant differences in plasma exemestane area under the curve for OATP1B1 genotype groups
In Utero Psychotropics + Opioids Up Neonatal Drug Withdrawal
Risk of withdrawal increased two-fold with in utero exposure to two or more psychotropics plus opioids
